Zheng Y - Search Results

1

Integrative analysis of mRNA and miRNA expression profiles reveals seven potential diagnostic biomarkers for non‑small cell lung cancer.

Zhang J, Li D, Zhang Y, Ding Z, Zheng Y, Chen S, Wan Y. Zhang J, et al. Among authors: zheng y. Oncol Rep. 2020 Jan;43(1):99-112. doi: 10.3892/or.2019.7407. Epub 2019 Nov 13. Oncol Rep. 2020. PMID: 31746439 Free PMC article.

2

Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.

Zheng YL, Wan YF, Zhou LY, Ye ML, Liu S, Xu CQ, He YQ, Chen JH. Zheng YL, et al. Am J Infect Control. 2013 Jul;41(7):e59-63. doi: 10.1016/j.ajic.2013.01.006. Epub 2013 Mar 21. Am J Infect Control. 2013. PMID: 23523521

3

Uric acid levels in obstructive sleep apnea patients with atrial fibrillation.

Wan YF, Zheng YL, Niu HY, Xu CQ, He YQ, Wang Y, Chen JH, Zheng DH. Wan YF, et al. Among authors: zheng dh, zheng yl. Arch Med Res. 2014 Feb;45(2):132-7. doi: 10.1016/j.arcmed.2013.11.006. Epub 2013 Dec 6. Arch Med Res. 2014. PMID: 24316394

4

Azithromycin attenuates pulmonary inflammation and emphysema in smoking-induced COPD model in rats.

Wan YF, Huang ZH, Jing K, Li J, Wang Y, Xu CQ, Chen JH, Zheng YL. Wan YF, et al. Among authors: zheng yl. Respir Care. 2015 Jan;60(1):128-34. doi: 10.4187/respcare.03344. Epub 2014 Sep 23. Respir Care. 2015. PMID: 25249648 Free article.

5

Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial.

He Y, Zheng Y, Xu C, Yang H, Wang Z, Zhou L, Wan Y, Zheng D, Zhu J. He Y, et al. Among authors: zheng d, zheng y. Clin Respir J. 2016 May;10(3):318-25. doi: 10.1111/crj.12219. Epub 2014 Nov 9. Clin Respir J. 2016. PMID: 25308771 Clinical Trial.

6

IL-17 protein levels in both induced sputum and plasma are increased in stable but not acute asthma individuals with obesity.

Chen JH, Qin L, Shi YY, Feng JT, Zheng YL, Wan YF, Xu CQ, Yang XM, Hu CP. Chen JH, et al. Respir Med. 2016 Dec;121:48-58. doi: 10.1016/j.rmed.2016.10.018. Epub 2016 Oct 28. Respir Med. 2016. PMID: 27888992 Free article.

7

Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1.

Chen JH, Zheng YL, Xu CQ, Gu LZ, Ding ZL, Qin L, Wang Y, Fu R, Wan YF, Hu CP. Chen JH, et al. Among authors: zheng yl. Biol Chem. 2017 Jun 27;398(7):785-792. doi: 10.1515/hsz-2016-0307. Biol Chem. 2017. PMID: 28002023

8

miR-448 is a novel prognostic factor of lung squamous cell carcinoma and regulates cells growth and metastasis by targeting DCLK1.

Shan C, Fei F, Li F, Zhuang B, Zheng Y, Wan Y, Chen J. Shan C, et al. Among authors: zheng y. Biomed Pharmacother. 2017 May;89:1227-1234. doi: 10.1016/j.biopha.2017.02.017. Epub 2017 Mar 17. Biomed Pharmacother. 2017. PMID: 28320089

9

Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer.

Chen JH, Zhou LY, Xu S, Zheng YL, Wan YF, Hu CP. Chen JH, et al. Cancer Cell Int. 2017 Jun 12;17:64. doi: 10.1186/s12935-017-0433-7. eCollection 2017. Cancer Cell Int. 2017. PMID: 28615992 Free PMC article.

10

MiR-484 promotes non-small-cell lung cancer (NSCLC) progression through inhibiting Apaf-1 associated with the suppression of apoptosis.

Li T, Ding ZL, Zheng YL, Wang W. Li T, et al. Biomed Pharmacother. 2017 Dec;96:153-164. doi: 10.1016/j.biopha.2017.09.102. Epub 2017 Oct 2. Biomed Pharmacother. 2017. PMID: 28982084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,195 results

Search Page

Filters